Staphylococcus aureus antigens and challenges in vaccine development

References

• Shinefield HR, Black S. Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev. Vaccines4(5), 669–676 (2005).
   PubMed Web of Science ®Google Scholar
• Sutra L, Poutrel B. Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus. J. Med. Microbiol.40(2), 79–89 (1994).
   PubMed Web of Science ®Google Scholar
• Paape MJ, Wergin WP, Guidry AJ et al. Phagocytic defense of the ruminant mammary gland. Adv. Exp. Med Biol.137, 555–578 (1981).
   PubMedGoogle Scholar
• Kent GM, Newbould FH. Phagocytosis and related phenomena in polymorphonuclear leukocytes from cow’s milk. Can. J. Comp. Med.33(3), 214–219 (1969).
   Google Scholar
• Paape MJ, Guidry AJ, Kirk ST et al. Measurement of phagocytosis of 32P-labeled Staphylococcus aureus by bovine leukocytes: lysostaphin digestion and inhibitory effect of cream. Am. J. Vet. Res.36(12), 1737–1743 (1975).
   Google Scholar
• Watson DL. The effect of cytophilic IgG2 on phagocytosis by ovine polymorphonuclear leucocytes. Immunology31(2), 159–165 (1976).
   Google Scholar
• Guidry AJ, Berning LM, Hambleton CN. Opsonization of Staphylococcus aureus by bovine immunoglobulin isotypes. J. Dairy Sci.76(5), 1285–1289 (1993).
   Google Scholar
• Barrio MB, Rainard P, Gilbert FB et al. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus. J. Dairy Sci.86(9), 2884–2894 (2003).
   Google Scholar
• Bannerman DD, Paape MJ, Lee JW et al.Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin. Diagn. Lab. Immunol.11(3), 463–472 (2004).
   PubMedGoogle Scholar
• Hermans K, Devriese LA, Haesebrouck F. Staphylococcus. In: Pathogenesis of Bacterial Infections in Animals (3rd Edition). Gyles CL, Prescott JF, Songer JG, Thoen CO (Eds). Blackwell Publishing, Ames, IA, USA 43–55. (2004).
   Google Scholar
• Peterson PK, Wilkinson BJ, Youngki K et al. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun.19(3), 943–939 (1978).
   PubMed Web of Science ®Google Scholar
• Peterson PK, Wilkinson BJ, Youngki K et al. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J. Clin. Invest.61(3), 597–609 (1978).
   PubMed Web of Science ®Google Scholar
• Watson DL. Vaccination against experimental staphylococcal mastitis in dairy heifers. Res. Vet. Sci.53(3), 346–353 (1992).
   PubMed Web of Science ®Google Scholar
• Williams JM, Mayerhofer HJ, Brown RW. Clinical evaluation of a Staphylococcus aureus bacterin (polyvalent somatic antigen). Vet. Med. Small Anim. Clin.61(8), 789–793 (1966).
   Google Scholar
• Williams JM, Shipley GR, Smith GL et al. A clinical evaluation of Staphylococcus aureus bacterin in the control of staphylococcal mastitis in cows. Vet. Med. Small Anim. Clin.70(5), 587–594 (1975).
   PubMedGoogle Scholar
• Brock JH, Steel ED, Reiter B. The effect of intramuscular and intramammary vaccination of cows on antibody levels and resistance to intramammary infection by Staphylococcus aureus. Res. Vet. Sci.19(2), 152–158 (1975).
   Google Scholar
• Middleton JR, Ma J, Rinehart CL et al. Efficacy of different Lysigin® formulations in the prevention of Staphylococcus aureus intramammary infection in dairy heifers. J. Dairy Res.73(1), 10–19 (2006).
   PubMedGoogle Scholar
• Luby CD, Middleton JR, Ma J et al. Characterization of the antibody isotype response in serum and milk of heifers vaccinated with a Staphylococcus aureus bacterin (Lysigin™). J. Dairy Res.74(2), 239–246 (2007).
   Google Scholar
• Leitner G, Lubashevsky E, Trainin Z. Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model. Vet. Immunol. Immunopathol.93(3–4), 159–167 (2003).
   Google Scholar
• Leitner G, Lubashevsky E, Glickman A et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows I. Challenge trials. Vet. Immunol. Immunopathol.93(3–4), 31–38 (2003).
   PubMedGoogle Scholar
• Leitner G, Yadlin N, Lubashevsky E et al. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows II. Field trial. Vet. Immunol. Immunopathol.93(3–4), 153–158 (2003).
   Google Scholar
• Lee JW, O’Brien CN, Guidry AJ et al. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis. Can. J. Vet. Res.69(1), 11–18 (2005).
   Google Scholar
• Sears PM, Belschner AP. Alternative management and economic consideration in Staphylococcus aureus elimination programs. Presented at: 38th National Mastitis Council Annual Meeting. Arlington, VA, USA, 14 –17 February 1999.
   Google Scholar
• Rizzo C, Brancaccio G, De Vito D et al. Efficacy of autovaccination therapy on post-coronary artery bypass grafting methicillin-resistant Staphylococcus aureus mediastinitis. Interact. Cardiovasc. Thorac. Surg.6(2), 228–229 (2007).
   Google Scholar
• Karakawa WW, Vann WF. Capsular polysaccharides of Staphylococcus aureus. In:Seminars in Infectious Disease. Neinstein L, Fields BN (Eds). Thieme-Stratton, NY, USA 285–293 (1982).
   Google Scholar
• Sompolinsky D, Samra Z, Karakawa WW et al. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J. Clin. Microbiol.22(5), 828–834 (1985).
   PubMed Web of Science ®Google Scholar
• Guidry A, Fattom A, Patel A et al. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am. J. Vet. Res.59(12), 1537–1539 (1998).
   PubMed Web of Science ®Google Scholar
• O’Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev.17(1), 218–234 (2004).
   PubMed Web of Science ®Google Scholar
• Jones C. Revised structures for the capsular polysaccharides from Staphylococcus aureus types 5 and 8, components of novel glycoconjugate vaccines. Carbohydr. Res.340(6), 1097–1106 (2005).
   PubMed Web of Science ®Google Scholar
• Guidry A, Fattom A, Patel A et al. Prevalence of capsular serotypes among Staphylococcus aureus isolates from cows with mastitis in the United States. Vet. Microbiol.59(1), 53–58 (1997).
   PubMed Web of Science ®Google Scholar
• Kenny K, Tollersrud T. Questions uniqueness of surface polysaccharide. Am. J. Vet. Res.60(5), 530 (1997).
   Google Scholar
• Verdier I, Durand G, Bes M et al. Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests. J. Clin. Microbiol.45(3), 725–729 (2007).
   PubMed Web of Science ®Google Scholar
• Cocchiaro JL, Gomez MI, Risley A et al. Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus. Mol. Microbiol.59(3), 948–960 (2006).
   PubMedGoogle Scholar
• Tollersrud T, Zernichow L, Anderson SR et al.Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle. Vaccine19(28–29), 3896–3903 (2001).
   PubMedGoogle Scholar
• Shinefield H, Black S, Fattom A et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med.346(7), 491–496 (2002).
   PubMed Web of Science ®Google Scholar
• Fattom AI, Horwith G, Fuller S et al. Development of StaphVAX®, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to Phase III clinical trials. Vaccine22(7), 880–887 (2004).
   PubMed Web of Science ®Google Scholar
• Fattom A, Fuller A, Propst M et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients. Vaccine23(5), 656–663 (2004).
   PubMed Web of Science ®Google Scholar
• Robbins JB, Schneerson R, Horwith G et al.Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. Am. Heart J.147(4), 593–598 (2004).
   PubMed Web of Science ®Google Scholar
• Nour El-Din AN, Shkreta L, Talbot BG et al. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus. Vaccine24(12), 1997–2006 (2006).
   PubMed Web of Science ®Google Scholar
• Gaudreau MC, Lacasse P, Talbot BG. Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus. Vaccine25(5), 814–824 (2007).
   PubMed Web of Science ®Google Scholar
• Brouillette E, Lacasse P, Shkreta L et al. DNA immunization against clumping factor A (ClfA) of Staphylococcus aureus. Vaccine20(17–18), 2348–2357 (2002).
   PubMed Web of Science ®Google Scholar
• Therrien R, Lacasse P, Grondin G et al. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein. Vaccine25(27), 5053–5061 (2007).
   PubMedGoogle Scholar
• Schaffer AC, Solinga RM, Cocchiaro J et al. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect. Immun.74(4), 2145–2153 (2006).
   PubMed Web of Science ®Google Scholar
• Zhou H, Xiong ZY, Li HP, Zhengy YL, Jiang XO. An immunogenicity study of a newly fusion protein Can–FnBP vaccinated against Staphylococcus aureus in a mice model. Vaccine24(22), 4830–4837 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson L, Flock JI, Hook M et al. Adhesins in staphylococcal mastitis as vaccine components. Flem. Vet. J.62(Suppl. 1), 111–125 (1990).
   Google Scholar
• McKenney D, Pouliot KL, Wang Y et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science284(5419), 1523–1527 (1999).
   PubMed Web of Science ®Google Scholar
• Maira-Litran T, Kropec A, Goldmann DA et al. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine22(7), 872–879 (2004).
   PubMed Web of Science ®Google Scholar
• Maira-Litran T, Kropec A, Goldmann DA et al. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-β-(1-6)-glucosamine. Infect. Immun.73(10), 6752–6762 (2005).
   PubMed Web of Science ®Google Scholar
• Kuklin NA, Clark DJ, Secore S et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect. Immun.74(4), 2215–2223 (2006).
   PubMed Web of Science ®Google Scholar
• Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc. Natl Acad. Sci. USA103(45), 16942–16947 (2006).
   PubMed Web of Science ®Google Scholar
• Senna JP, Roth DM, Oliveira JS et al. Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine. Vaccine21(19–20), 2661–2666 (2003).
   PubMed Web of Science ®Google Scholar
• Roth DM, Senna JPM, Machado DC. Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus. Genet. Mol. Res.5(3), 503–512 (2006).
   PubMed Web of Science ®Google Scholar
• Ohwada A, Sekiya M, Hanaki H et al. DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother.44(6), 767–774 (1999).
   Google Scholar
• Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med.205(2), 287–294 (2008).
   Google Scholar
• DeLeo FR, Otto M. An antidote for Staphylococcus aureus pneumonia? J. Exp. Med.205(2), 271–274 (2008).
   PubMed Web of Science ®Google Scholar
• Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun.75(2), 1040–1044 (2007).
   Google Scholar
• Adlam C, Ward PD, McCartney CA et al. Effect of immunization with highly purified α- and β-toxins on staphylococcal mastitis in rabbits. Infect. Immun.17(2), 250–256 (1977).
   PubMed Web of Science ®Google Scholar
• Menzies BE, Kernodle DS. Passive immunization with antiserum to a nontoxic α-toxin mutant from Staphylococcus aureus is protective in a murine model. Infect. Immun.64(5), 1839–1841 (1996).
   PubMedGoogle Scholar
• Hume EB, Dajcs JJ, Moreau JM et al. Immunization with α-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infect. Immun.68(10), 6052–6055 (2000).
   PubMed Web of Science ®Google Scholar
• Hu DL, Omoe K, Sasaki S et al. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J. Infect. Dis.188(5), 743–752 (2003).
   PubMed Web of Science ®Google Scholar
• Cui JC, Hu DL, Lin YC et al. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection. FEMS Immunol. Med. Microbiol.45(1), 45–51 (2005).
   Google Scholar
• Hu DL, Omoe K, Narita K et al. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection. Microbes Infect.8(14–15), 2841–2848 (2006).
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansmann MA, Delaney ML et al. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol.43(9), 4628–4634 (2005).
   PubMed Web of Science ®Google Scholar
• Chang BS, Moon JS, Kang H et al. Protective effects of recombinant staphylococcal enterotxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle. Vaccine26(17), 2081–2091 (2008).
   PubMed Web of Science ®Google Scholar
• Goji N, Potter AA, Perez-Casal J. Characterization of two proteins of Staphylococcus aureus isolated from bovine clinical mastitis with homology to glyceraldehyde-3-phosphate dehydrogenase. Vet. Microbiol.99(3–4), 269–279 (2004).
   Google Scholar
• Fontaine MC, Perez-Casal J, Song XM et al. Immunisation of dairy cattle with recombinant Streptococcus uberis GapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge. Vaccine20(17–18), 2278–2286 (2002).
   PubMedGoogle Scholar
• Perez-Casal J, Prysliak T, Kerro-Dego O et al. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis. Vet. Immunol. Immunopathol.109(1–2), 85–97 (2006).
   Google Scholar
• Kerro-Dego O, Prysliak T, Potter AA et al. DNA–protein immunization against GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus. Vet. Immunol. Immunopathol.113(1–2), 125–138 (2006).
   Google Scholar
• Balaban N, Goldkorn T, Nahn RT et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science280(5362), 438–440 (1998).
   PubMed Web of Science ®Google Scholar
• Yang G, Gao Y, Dong J et al. A novel peptide screened by phage display can mimic TRAP antigen epitope against Staphylococcus aureus infections. J. Biol. Chem.280(29), 27431–27435 (2005).
   PubMedGoogle Scholar
• Yang G, Gao Y, Dong J et al. A novel peptide isolated from phage library to substitute a complex system for a vaccine against staphylococcal infection. Vaccine24(8), 1117–1123 (2006).
   PubMed Web of Science ®Google Scholar
• Pellegrino M, Giraudo J, Raspanti C et al. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis. Vet. Microbiol.127(1–2), 186–190 (2008).
   Google Scholar
• Bogni C, Segura M, Giraudo et al. Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant. Can. J. Vet. Res.62(4), 293–298 (1998).
   Google Scholar
• Buzzola FR, Barbagelata MS, Caccuri RL et al. Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice. Infect. Immun.74(6), 3498–3506 (2006).
   Google Scholar
• Weisman LE. Antibody for the prevention of neonatal nosocomial staphylococcal infection: a review of the literature. Arch. Pediatr.14(Suppl. 1), S31–S34 (2007).
   Google Scholar
• Ma J, Cocchiaro J, Lee JC. Evaluation of serotypes of Staphylococcus aureus strains used in the production of a bovine mastitis bacterin. J. Dairy Sci.87(1), 178–182 (2004)
   Google Scholar
• Pankey JW, Boddie NT, Watts JL et al. Evaluation of protein A and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by experimental challenge. J. Dairy Sci.68(3), 726–731 (1985).
   PubMed Web of Science ®Google Scholar
• Nickerson SC, Owens WE, Tomita GM et al. Vaccinating dairy heifers with a Staphylococcus aureus bacterin reduces mastitis at calving. Large Animal Practice20, 16–28 (1999).
   Google Scholar
• Fox LK, Chester ST, Hallberg JW et al. Survey of intramammary infections in dairy heifers at breeding age and first parturition. J. Dairy Sci.78(7), 1619–1628 (1995).
   Google Scholar
• Risley AL, Loughman A, Cywes-Bentley C et al. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets. J. Infect. Dis.196(6), 919–927 (2007).
   Google Scholar
• Dryla A, Prustomersky S, Glebmann D et al. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab Immunol.12(3), 387–398 (2005).
   PubMedGoogle Scholar
• Clarke SR, Brummell KJ, Horsburgh MJ et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect. Dis.193(8), 1098–1108 (2006).
   PubMed Web of Science ®Google Scholar
• Weichhart T, Horky M, Sollner J et al. Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect. Immun.71(8), 4633–4641 (2003).
   PubMed Web of Science ®Google Scholar